Free Trial

Celsius (NASDAQ:CELH) Posts Quarterly Earnings Results, Beats Expectations By $0.07 EPS

Celsius (NASDAQ:CELH - Get Free Report) released its quarterly earnings data on Tuesday. The company reported $0.27 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.20 by $0.07, Briefing.com reports. Celsius had a return on equity of 131.58% and a net margin of 17.21%. The firm had revenue of $355.70 million during the quarter, compared to analyst estimates of $390.37 million. During the same period in the prior year, the company posted $0.13 earnings per share. The business's revenue for the quarter was up 36.9% compared to the same quarter last year.

Celsius Stock Up 0.2 %

NASDAQ CELH traded up $0.18 during trading hours on Wednesday, hitting $77.13. The company's stock had a trading volume of 5,832,819 shares, compared to its average volume of 4,793,541. The stock has a fifty day moving average of $81.42 and a 200 day moving average of $65.97. Celsius has a twelve month low of $34.74 and a twelve month high of $99.62. The firm has a market capitalization of $17.82 billion, a P/E ratio of 99.74, a PEG ratio of 2.22 and a beta of 1.93.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on CELH. UBS Group dropped their target price on shares of Celsius from $99.00 to $92.00 and set a "buy" rating for the company in a research report on Wednesday. Morgan Stanley reiterated an "equal weight" rating and issued a $75.00 target price on shares of Celsius in a research note on Wednesday, March 27th. Roth Mkm raised their price target on Celsius from $90.00 to $105.00 and gave the company a "buy" rating in a report on Thursday, March 14th. Jefferies Financial Group boosted their price objective on Celsius from $98.00 to $105.00 and gave the stock a "buy" rating in a research note on Monday, March 18th. Finally, Piper Sandler raised their target price on Celsius from $76.00 to $90.00 and gave the company an "overweight" rating in a research note on Friday, March 1st. Two research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $84.95.


View Our Latest Report on CELH

Insider Buying and Selling at Celsius

In other news, Director Nicholas Castaldo sold 165,000 shares of the firm's stock in a transaction on Monday, March 4th. The stock was sold at an average price of $83.33, for a total value of $13,749,450.00. Following the transaction, the director now directly owns 352,864 shares in the company, valued at approximately $29,404,157.12. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Celsius news, Director Nicholas Castaldo sold 165,000 shares of the stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $83.33, for a total value of $13,749,450.00. Following the completion of the sale, the director now directly owns 352,864 shares in the company, valued at $29,404,157.12. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CMO Kyle Audrey Watson sold 40,000 shares of the firm's stock in a transaction that occurred on Tuesday, March 12th. The stock was sold at an average price of $89.17, for a total transaction of $3,566,800.00. Following the sale, the chief marketing officer now owns 75,060 shares in the company, valued at $6,693,100.20. The disclosure for this sale can be found here. In the last 90 days, insiders sold 2,043,363 shares of company stock worth $131,361,140. Insiders own 2.20% of the company's stock.

Celsius Company Profile

(Get Free Report)

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.

Recommended Stories

Earnings History for Celsius (NASDAQ:CELH)

Should you invest $1,000 in Celsius right now?

Before you consider Celsius, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Celsius wasn't on the list.

While Celsius currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Featured Articles and Offers

Palantir Stock Solid Earnings, Sudden Drop

Palantir Stock Solid Earnings, Sudden Drop

Palantir continues to attract both traders and long-term investors. If you're in the latter category, the story hasn't changed. If anything, it's getting stronger.

Search Headlines: